Esej
https://doi.org/10.3325/cmj.2021.62.528
A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents
Marija Bogadi
orcid.org/0000-0002-5266-762X
; Psychiatric Hospital for Children and Adolescents, Zagreb, Croatia
Snježana Kaštelan
orcid.org/0000-0002-3983-1157
; University of Zagreb School of Medicine, Zagreb, Croatia
Sažetak
Psilocybin is a naturally occurring psychedelic substance
present in a variety of Psilocybe mushroom species (1). It
has been used in different cultures since prehistoric times
to induce hallucinations and altered states of consciousness (2). Upon ingestion, psilocybin is transformed into a
pharmacologically active ingredient psilocin. It affects a
number of serotonin receptors, but has the highest affinity for serotonin 2A receptor. The effects of psilocybin are
dose-dependent and include perceptual, cognitive, and
emotional changes (1,3-5). The drug improves mood instantly, but the effects may last over several months, during which time psychotherapeutic interventions can be
used (5-7). In 1959, while working for Sandoz Pharmaceuticals, Albert Hofmann isolated purified psilocybin from Psilocybe mushrooms, which was registered under the commercial name Indocybin (8). However, increased misuse of
psychedelic drugs in the late 1960s led to the prohibition
of production, trade, and consumption of hallucinogenic
drugs (9). Even though psilocybin was banned in many
countries, including Croatia, over time its therapeutic benefit has been demonstrated. Several studies have shown
its usefulness in managing treatment-resistant depression, anxiety, and depression in life-threatening diseases,
obsessive-compulsive disorder, alcohol and smoking dependence, posttraumatic stress disorder, and cluster headaches (10-16). However, the available research has not covered its impact in children and adolescents
Ključne riječi
Hrčak ID:
278802
URI
Datum izdavanja:
21.10.2021.
Posjeta: 1.129 *